Cargando…
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461338/ https://www.ncbi.nlm.nih.gov/pubmed/36096426 http://dx.doi.org/10.1016/j.phrs.2022.106445 |
| _version_ | 1784786953838788608 |
|---|---|
| author | Tseng, Yu-Hwei Lin, Sunny Jui-Shan Lee, Ming-Yung Su, Yi-Chang |
| author_facet | Tseng, Yu-Hwei Lin, Sunny Jui-Shan Lee, Ming-Yung Su, Yi-Chang |
| author_sort | Tseng, Yu-Hwei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9461338 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94613382022-09-10 Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 Tseng, Yu-Hwei Lin, Sunny Jui-Shan Lee, Ming-Yung Su, Yi-Chang Pharmacol Res Article Published by Elsevier Ltd. 2022-11 2022-09-09 /pmc/articles/PMC9461338/ /pubmed/36096426 http://dx.doi.org/10.1016/j.phrs.2022.106445 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Tseng, Yu-Hwei Lin, Sunny Jui-Shan Lee, Ming-Yung Su, Yi-Chang Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title | Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title_full | Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title_fullStr | Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title_full_unstemmed | Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title_short | Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3 |
| title_sort | treating covid-19 with nricm101 and nricm102 – author’s reply 3 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461338/ https://www.ncbi.nlm.nih.gov/pubmed/36096426 http://dx.doi.org/10.1016/j.phrs.2022.106445 |
| work_keys_str_mv | AT tsengyuhwei treatingcovid19withnricm101andnricm102authorsreply3 AT linsunnyjuishan treatingcovid19withnricm101andnricm102authorsreply3 AT leemingyung treatingcovid19withnricm101andnricm102authorsreply3 AT suyichang treatingcovid19withnricm101andnricm102authorsreply3 |